FLI-1 is a suppressor of erythroid differentiation in human hematopoietic cells

Leukemia

Volumn 14, Issue 3, 2000, Pages 439-445

  Athanasiou, M ^a   Mavrothalassitis, G ^b   Sun Hoffman, L ^c   Blair, D G ^b,c  

^a SAIC FREDERICK INC   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c INSTITUTE OF COMPUTER SCIENCE   (Greece)

Author keywords

Erythroid differentiation; ETS transcription factors; FLI 1; GATA 1; GATA 1 promoter; K562

Indexed keywords

CELL SURFACE MARKER; CYTARABINE; HEMIN; MESSENGER RNA; ONCOPROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ETS 1; TRANSCRIPTION FACTOR ETS 2; TRANSCRIPTION FACTOR FLI 1; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR GATA 2; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL STRAIN K 562; CONTROLLED STUDY; ERYTHROID CELL; GENE OVEREXPRESSION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; MEGAKARYOCYTE; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REPORTER GENE;

EID: 0034093726     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401689     Document Type: Article

References (52)

1. Quang CT, Pironin M, von Lindern M, Beug H, Ghysdael J. Spi-1 and mutant p53 regulate different aspects of the proliferation and differentiation control of primary erythroid progenitors. Oncogene 1995; 11: 1229-1239.
2. Carrere S, Verger A, Flourens A, Stehelin D, Duterque-Coquillaud M. Erg proteins, transcription factors of the Ets family, form homo, heterodimers and ternary complexes via two distinct domains. Oncogene 1998; 16: 3261-3268.
3. Anderson MK, Hernandez-Hoyos G, Diamond RA, Rothenberg EV. Precise developmental regulation of Ets family transcription factors during specification and commitment to the T cell lineage. Development 1999; 126: 3131-3148.
4. Nunn M, Weiher H, Bullock P, Duesberg P. Avian erythroblastosis virus E26: nucleotide sequence of the tripartite onc gene and of the LTR, and analysis of the cellular prototype of the viral ets sequence. Virology 1984; 139: 330-339.
5. Moscovici C, Samarut J, Gazzolo L, Moscovici MG. Myeloid and erythroid neoplastic responses to avian defective leukemia viruses in chickens and in quail. Virology 1981; 113: 765-768.
6. Yuan CC, Kan N, Dunn KJ, Papas TS , Blair DG. Properties of a murine retroviral recombinant of avian acute leukemia virus E26: a murine fibroblast assay for v-ets function. J Virol 1989; 63: 205-215.
7. Ben-David Y, Bernstein A. Friend virus-induced erythroleukemia and the multistage nature of cancer. Cell 1991; 66: 831-834.
8. Ben-David Y, Giddens EB, Letwin K, Bernstein A. Erythroleukemia induction by Friend murine leukemia virus: insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1. Genes Dev 1991; 5: 908-918.
9. Ott DE, Keller J, Rein A. 10A1 MuLV induces a murine leukemia that expresses hematopoietic stem cell markers by a mechanism that includes fli-1 integration. Virology 1994; 205: 563-568.
10. Delattre O, Zucman J, Plougastel B, Desmaze C, Melot T, Peter M, Kovar H, Joubert I, de long P, Rouleau G et al. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 1992; 359: 162-165.
11. Dittmer J, Nordheim A. Ets transcription factors and human disease. Biochim Biophys Acta 1998; 1377: F1-11.
12. Starck J, Doubeikovski A, Sarrazin S, Gonnet C, Rao G, Skoultchi A, Godet J, Dusanter-Fourt I, Morle F. Spi-1/PU.1 is a positive regulator of the Fli-1 gene involved in inhibition of erythroid differentiation in friend erythroleukemic cell lines. Mol Cell Biol 1999; 19: 121-135.
13. Klemsz MJ, McKercher SR, Celada A, Van Beveren C , Maki RA. The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene. Cell 1990; 61: 113-124.
14. Moreau-Gachelin F, Tavitian A , Tambourin P. Spi-1 is a putative oncogene in virally induced murine erythroleukaemias. Nature 1988; 331: 277-280.
15. Watson DK, Smyth FE, Thompson DM, Cheng JQ, Testa JR, Papas TS, Seth A. The ERGB/Fli-1 gene: isolation and characterization of a new member of the family of human ETS transcription factors. Cell Growth Differ 1992; 3: 705-713.
16. Athanasiou M, Clausen PA, Mavrothalassitis GJ, Zhang XK, Watson DK, Blair DG. Increased expression of the ETS-related transcription factor FLI-1/ERGB correlates with and can induce the megakaryocytic phenotype. Cell Growth Differ 1996; 7: 1525-1534.
17. Shivdasani RA, Fujiwara Y, McDevitt MA, Orkin SH. A lineage-selective knockout establishes the critical role of transcription factor GATA-I in megakaryocyte growth and platelet development. EMBO J 1997; 16: 3965-3973.
18. McKercher SR, Torbett BE, Anderson KL, Henkel GW, Vestal DJ, Baribault H, Klemsz M, Feeney AJ, Wu GE, Paige CJ , Maki RA. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J 1996; 15: 5647-5658.
19. Takahashi S, Komeno T, Suwabe N, Yoh K, Nakajima O, Nishimura S, Kuroha T, Nagasawa T, Yamamoto M. Role of GATA-1 in proliferation and differentiation of definitive erythroid and megakaryocytic cells in vivo. Blood 1998; 92: 434-442.
20. Tsang AP, Fujiwara Y, Hom DB, Orkin SH. Failure of megakaryopoiesis and arrested erythropoiesis in mice lacking the GATA-1 transcriptional cofactor FOG. Genes Dev 1998; 12: 1176-1188.
21. Valtieri M, Tocci A, Gabbianelli M, Luchetti L, Masella B, Vitelli L, Botta R, Testa U, Condorelli GL, Peschle C. Enforced TAL-1 expression stimulates primitive, erythroid and megakaryocytic progenitors but blocks the granulopoietic differentiation program. Cancer Res 1998; 58: 562-569.
22. Rowley PT, Ohlsson-Wilhelm BM, Farley BA , LaBella S. Inducers of erythroid differentiation in K562 human leukemia cells. Exp Hematol 1981; 9: 32-37.
23. Athanasiou M, Mavrothalassitis GJ, Yuan CC , Blair DG. The Gag-Myb-Ets fusion oncogene alters the apoptotic: response and growth factor dependence of interleukin-3 dependent murine cells. Oncogene 1996; 12: 337-344.
24. Martin P, Papayannopoulou T. HEL cells: a new human erythroleukemia cell line with spontaneous and induced globin expression. Science 1982; 216: 1233-1235.
25. Andersson LC, Jokinen M , Gahmberg CG. Induction of erythroid differentiation in the human leukaemia cell line K562. Nature 1979; 278: 364-365.
26. Romano-Spica V, Suzuki H, Georgiou P, Chen S-L, Ascione R, Papas TS, Bhat NK. Expression of ets family genes in hematopoietic cells, Intl J Oncol 1994; 4: 521-531.
27. Jarvinen M. Vimentin in human erythroleukemia (HEL) cells is modulated with differentiation inducers. Cell Biol Int Rep 1990; 14: 199-209.
28. Clausen P, Athanasiou M, Chen Z-Q, Dunn KJ, Zhang Q, Lautenberger JA, Mavrothalassitis G, Blair DG. ETS-1 induces increased expression of erythroid markers in the pluripotent erythroleukemic cell lines K562 and HEL. Leukemia 1997; 11: 1224-1233.
29. Andersson LC, Jokinen M, Klein E, Klein G, Nilsson K. Presence of erythrocytic components in the K562 cell line (letter), Int J Cancer 1979; 24: 514.
30. Gahmberg CG, Jokinen M, Andersson LC. Expression of the major red cell sialoglycoprotein, glycophorin A, in the human leukemic cell line K562. J Biol Chem 1979; 254: 7442-7448.
31. Rutherford TR, Clegg JB, Weatherall DJ. K562 human leukaemic cells synthesise embryonic haemoglobin in response to haemin. Nature 1979; 280: 164-165.
32. Pevny L, Lin CS, D'Agati V, Simon MC, Orkin SH , Costantini F. Development of hematopoietic cells lacking transcription factor GATA-1. Development 1995; 121: 163-172.
33. Weiss MJ , Orkin SH. GATA transcription factors: key regulators of hematopoiesis. Exp Hemqtol 1995; 23: 99-107.
34. Orkin SH. Hematopoiesis: how does it happen? Curr Opin Cell Biol 1995; 7: 870-877.
35. Sun-Hoffman L, Aurigemma RE, Sun B, Ruscetti SK. Transactivation of the GATA-1 promoter by a myb-ets-containing mouse retrovirus is mediated by CACCC elements. Oncogene 1996; 13: 1037-1042.
36. Baron MH, Farrington SM. Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells. Mol Cell Biol 1994; 14: 3108-3114.
37. Tsai SF, Strauss E, Orkin SH. Functional analysis and in vivo foot-printing implicate the erythroid transcription factor GATA-1 as a positive regulator of its own promoter. Genes Dev 1991; 5: 919-931.
38. Robert-Lezenes J, Meneceur P, Ray D, Moreau-Garhelin F. Protooncogene expression in normal, preleukemic, and leukemic murine erythroid cells and its relationship to differentiation and proliferation (published erratum appears in Cancer Res 1988 Sep 1; 48(17): 5056). Cancer Res 1988; 48: 3972-3976.
39. Ben-David Y, Giddens EB, Bernstein A. Identification and mapping of a common proviral integration site Fli-1 in erythroleukemia cells induced by Friend murine leukemia virus. Proc Natl Acad Sci USA 1990; 87: 1332-1336.
40. Kwiatkowski BA, Bastian LS, Bauer TR Jr, Tsai S, Zielinska-Kwiatkowska AG, Hickstein DD. The ets family member Tel binds to the Fli-1 oncoprotein and inhibits its transcriptional activity. J Biol Chem 1998; 273: 17525-17530.
41. Rekhtman N, Radparvar F, Evans T, Skoultchi AI. Direct interaction of hematopoietic transcription factors PU.1 and GATA-1: functional antagonism in erythroid cells. Genes Dev 1999; 13: 1398-1411.
42. Pereira R, Quang CT, Lesault I, Dolznig H, Beug H, Ghysdael J. FLI-1 inhibits differentiation and induces proliferation of primary erythroblasts. Oncogene 1999; 18: 1597-1608.
43. Tamir A, Howard J, Higgins RR, Li YJ, Berger L, Zacksenhaus E, Reis M, Ben-David Y. Fli-1, an ets-related transcription factor, regulates erythropoietin-induced erythroid proliferation and differentiation: evidence for direct transcriptional repression of the Rb gene during differentiation. Mol Cell Biol 1999; 19: 4452-4464.
44. Plumb M, Frampton J, Wainwright H, Walker M, Macleod K, Goodwin G, Harrison P. GATAAG; a cis-control region binding an erythroid-specific nuclear factor with a role in globin and non-globin gene expression. Nucleic Acids Res 1989; 17: 73-92.
45. Romeo PH, Prandini MH, Joulin V, Mignotte V, Prenant M, Vainchenker W, Marguerie G, Uzan G. Megakaryocytic and erythrocytic lineages share specific transcription factors. Nature 1990; 344: 447-449.
46. Orkin SH. GATA-binding transcription factors in hematopoietic cells. Blood 1992; 80: 575-581.
47. Pevny L, Simon MC, Robertson E, Klein WH, Tsai SF, D'Agati V, Orkin SH, Costantini F. Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature 1991; 349: 257-260.
48. McNagny KM, Sieweke MH, Doderlein G, Graf T , Nerlov C. Regulation of eosinophil-specific gene expression by a C/EBP-Ets complex and GATA-1. EMBO J 1998; 17: 3669-3680.
49. Minami T, Tachibana K, Imanishi T, Doi T. Both Ets-1 and GATA-1 are essential for positive regulation of platelet factor 4 gene expression. Eur J Biochem 1998; 258: 879-889.
50. Moreau-Gachelin F, Ray D, Mattei MG, Tambourin P, Tavitian A. The putative oncogene Spi-1: murine chromosomal localization and transcriptional activation in murine acute erythroleukemias (published erratum appears in Oncogene 1990 Jun; 5(6): 941). Oncogene 1989; 4: 1449-1456.
51. Delgado MD, Gutierrez P, Richard C, Cuadrado MA, Moreau-Gachelin F, Leon J. Spi-1/PU.1 proto-oncogene induces opposite effects on monocytic and erythroid differentiation of K562 cells. Biochem Biophys Res Commun 1998; 252: 383-391.
52. Yamada T, Kondoh N, Matsumoto M, Yoshida M, Maekawa A, Oikawa T. Overexpression of PU.1 induces growth and differentiation inhibition and apoptotic cell death in murine erythroleukemia cells. Blood 1997; 89: 1383-1393.